Description
Nanobiomaterials and Nanomedicines for Metabolic Disorders delves into the transformative role of nanotechnology in addressing metabolic disorders. The book begins with an overview of nanoparticle classifications and then explores the synthesis of biomaterials and drug delivery systems. In addition, it explores innovative diagnostic and imaging techniques while presenting cutting-edge therapeutic approaches. Later chapters focus on specific metabolic disorders, such as cardiovascular and lifestyle-related conditions. The book is tailored to researchers, students, and healthcare professionals seeking advanced theranostic approaches to these disorders. By bridging nanotechnology with metabolic pathways, the text offers insights into how targeted nanomedicines can improve therapeutic outcomes.- Utilizes an interdisciplinary approach, bridging the fields of materials science and biomedical science to improve translational efficiency- Covers a range of nanoparticles and nanotechnologies for the diagnosis and treatment of metabolic disorders, aiding readers to select the most suitable for their work- Details various metabolic pathways and disorders, including glycogen and lysosomal storage, type 2 diabetes, obesity, and metabolic vascular disorders
Table of Contents
Section I: Nanomedicines for metabolic disorders: drug delivery1. Clinical use of inorganic and organic nanoparticles in metabolic syndromes2. Application of nanomedicines in mitigating oxidative stress3. Nanomedicines to enhance oral bioavailability for metabolic disorders4. Nanotechnology for the therapeutic use of biologics to treat metabolic disordersSection II: Nanotechnology in metabolic disorders: diagnosis and therapy5. Application of quantum dots in metabolic disorders6. Medical imaging using nanotechnology7. Nanorobotics: applications in metabolic disorders8. Nanomaterials for three-dimensional printing in management of metabolic disordersSection III: Nanomedicines for lifestyle metabolic disorders9. Nanomedicines to alleviate hepatic metabolic disorders10. Role of nanomedicines in type 2 diabetes11. Nanomedicines for precise therapy in hyperlipidaemia & obesitySection IV: Nanomedicines for cellular metabolic disorders12. Application of nanotechnology in lysosomal storage diseases13. Nanotechnology to target autophagy-mediated metabolic disorders14. Application of nanomedicines in glycogen storage diseasesSection V: Nanomedicines for metabolic cardiovascular diseases15. Nanotechnology for metabolic vascular diseases16. Nanomedicines for the management of atherosclerosis
